Real-world effectiveness of pangenotypic direct-acting antivirals in chronic hepatitis C
The aim of this study was to evaluate virological response, biochemical changes, and treatment tolerability in patients with chronic hepatitis C receiving pangenotypic direct-acting antiviral (DAA) therapy. The study included patients with chronic hepatitis C virus infection followed at a tertiary care center between 2...